Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Development and in-house validation of a rapid and simple to use ELISA for the detection and measurement of the mycotoxin sterigmatocystin.

Oplatowska-Stachowiak M, Reiring C, Sajic N, Haasnoot W, Brabet C, Campbell K, Elliott CT, Salden M.

Anal Bioanal Chem. 2018 May;410(12):3017-3023. doi: 10.1007/s00216-018-0988-8. Epub 2018 Mar 9.

PMID:
29523941
2.

T-2 Toxin/HT-2 Toxin and Ochratoxin A ELISAs Development and In-House Validation in Food in Accordance with the Commission Regulation (EU) No 519/2014.

Oplatowska-Stachowiak M, Kleintjens T, Sajic N, Haasnoot W, Campbell K, Elliott CT, Salden M.

Toxins (Basel). 2017 Nov 30;9(12). pii: E388. doi: 10.3390/toxins9120388.

3.

ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.

van Beers JJ, Willemze A, Jansen JJ, Engbers GH, Salden M, Raats J, Drijfhout JW, van der Helm-van Mil AH, Toes RE, Pruijn GJ.

Arthritis Res Ther. 2013 Oct 1;15(5):R140. doi: 10.1186/ar4322.

4.

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.

Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD.

Arthritis Rheum. 2003 Aug;48(8):2146-54.

Supplemental Content

Loading ...
Support Center